Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Mathew

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
The Canadian Journal of Cardiology|February 8, 2025
Evaluating Volume and Resource Needs for Implementing an ST-Elevation Myocardial Infarction Shock ProtocolRene Boudreau, Michel Le May, Nikita Malhotra, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|March 20, 2025
Point-of-Care Ultrasound for the Detection of Vascular Access Site Complications-The ULTRASITCOM StudyPietro Di Santo, Omar Abdel-Razek, Graeme Prosperi-Porta, et al.
The New England Journal of Medicine|August 4, 2021
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic ShockRebecca Mathew, Pietro Di Santo, Richard G Jung, et al.
Critical Care (London, England)|June 16, 2026
Evaluating possible treatment effect heterogeneity in a randomized trial of milrinone versus dobutamine in cardiogenic shockLucas L Marinho, Gabriele Lileikyte, Philippe Boileau, et al.
Intensive Care Medicine|May 2, 2024
Mental health sequelae in survivors of cardiogenic shock complicating myocardial infarction. A population-based cohort studyShannon M Fernando, Danial Qureshi, Robert Talarico, et al.
Cell Stem Cell|May 25, 2026
Human amygdala-like telencephalic organoids model stress circuitry in assembloid systemsWoo Sub Yang, Mu Seog Choe, Cynthia Lo, et al.
Eclinicalmedicine|January 13, 2025
Identifying biomarker-driven subphenotypes of cardiogenic shock: analysis of prospective cohorts and randomized controlled trialsSabri Soussi, Tuukka Tarvasmäki, Antoine Kimmoun, et al.
Critical Care Medicine|January 8, 2026
Prognostic Factors Among Patients Receiving Microaxial Flow Pump for Acute Myocardial Infarction-Related Cardiogenic Shock: A Systematic Review and Meta-AnalysisSimon Parlow, Richard G Jung, Sayed Abdulmotaleb Almoosawy, et al.
Cancer Discovery|September 5, 2020
Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint BlockadeFrederick J Kohlhapp, Dipica Haribhai, Rebecca Mathew, et al.
American Heart Journal|April 24, 2023
Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trialSimon Parlow, Pietro Di Santo, Lee H Sterling, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
The Canadian Journal of Cardiology|February 8, 2025
Evaluating Volume and Resource Needs for Implementing an ST-Elevation Myocardial Infarction Shock ProtocolRene Boudreau, Michel Le May, Nikita Malhotra, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|March 20, 2025
Point-of-Care Ultrasound for the Detection of Vascular Access Site Complications-The ULTRASITCOM StudyPietro Di Santo, Omar Abdel-Razek, Graeme Prosperi-Porta, et al.
The New England Journal of Medicine|August 4, 2021
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic ShockRebecca Mathew, Pietro Di Santo, Richard G Jung, et al.
Critical Care (London, England)|June 16, 2026
Evaluating possible treatment effect heterogeneity in a randomized trial of milrinone versus dobutamine in cardiogenic shockLucas L Marinho, Gabriele Lileikyte, Philippe Boileau, et al.
Intensive Care Medicine|May 2, 2024
Mental health sequelae in survivors of cardiogenic shock complicating myocardial infarction. A population-based cohort studyShannon M Fernando, Danial Qureshi, Robert Talarico, et al.
Cell Stem Cell|May 25, 2026
Human amygdala-like telencephalic organoids model stress circuitry in assembloid systemsWoo Sub Yang, Mu Seog Choe, Cynthia Lo, et al.
Eclinicalmedicine|January 13, 2025
Identifying biomarker-driven subphenotypes of cardiogenic shock: analysis of prospective cohorts and randomized controlled trialsSabri Soussi, Tuukka Tarvasmäki, Antoine Kimmoun, et al.
Critical Care Medicine|January 8, 2026
Prognostic Factors Among Patients Receiving Microaxial Flow Pump for Acute Myocardial Infarction-Related Cardiogenic Shock: A Systematic Review and Meta-AnalysisSimon Parlow, Richard G Jung, Sayed Abdulmotaleb Almoosawy, et al.
Cancer Discovery|September 5, 2020
Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint BlockadeFrederick J Kohlhapp, Dipica Haribhai, Rebecca Mathew, et al.
American Heart Journal|April 24, 2023
Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trialSimon Parlow, Pietro Di Santo, Lee H Sterling, et al.
Pageof 12